RCEL
AVITA Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$15.65
−6.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 487.90x
- P/S forward
- 4.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -17.39x
- Price / sales
- 6.40x
- Price / cash flow
- -19.98x
Enterprise value
- Enterprise value
- $521.4M
- EV / sales
- 6.89x
- EV / EBITDA
- -14.82x
- EV / EBIT
- -14.80x
- Market cap
- $484.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026